122 related articles for article (PubMed ID: 26147217)
1. Interactions between histamine H1 receptor and its antagonists by using cell membrane chromatography method.
Ma W; Zhang D; Li J; Che D; Liu R; Zhang J; Zhang Y
J Pharm Pharmacol; 2015 Nov; 67(11):1567-74. PubMed ID: 26147217
[TBL] [Abstract][Full Text] [Related]
2. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
[TBL] [Abstract][Full Text] [Related]
3. Characterization of histamine type 1 receptors on natural suppressor lymphoid cells.
Khan MM; Wilson AL; Melmon KL
Biochem Pharmacol; 1987 Nov; 36(22):3867-71. PubMed ID: 2891358
[TBL] [Abstract][Full Text] [Related]
4. High-affinity binding of [3H]doxepin to histamine H1-receptors in rat brain: possible identification of a subclass of histamine H1-receptors.
Taylor JE; Richelson E
Eur J Pharmacol; 1982 Mar; 78(3):279-85. PubMed ID: 7067728
[TBL] [Abstract][Full Text] [Related]
5. Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization.
Hishinuma S; Sato Y; Kobayashi Y; Komazaki H; Saito M
J Pharmacol Sci; 2008 May; 107(1):66-79. PubMed ID: 18446005
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
7. Histamine H1 receptors in human brain labelled with [3H]doxepin.
Kanba S; Richelson E
Brain Res; 1984 Jun; 304(1):1-7. PubMed ID: 6146381
[TBL] [Abstract][Full Text] [Related]
8. [3H]doxepin interactions with histamine H1-receptors and other sites in guinea pig and rat brain homogenates.
Tran VT; Lebovitz R; Toll L; Snyder SH
Eur J Pharmacol; 1981 Apr; 70(4):501-9. PubMed ID: 7238574
[TBL] [Abstract][Full Text] [Related]
9. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Sawai Y; Ito K; Itoh M
Br J Pharmacol; 1995 Sep; 116(1):1649-55. PubMed ID: 8564232
[TBL] [Abstract][Full Text] [Related]
10. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
[TBL] [Abstract][Full Text] [Related]
11. Structural Analysis of the Histamine H
Shiroishi M; Kobayashi T
Handb Exp Pharmacol; 2017; 241():21-30. PubMed ID: 27826702
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
Laduron PM; Janssen PF; Gommeren W; Leysen JE
Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
[TBL] [Abstract][Full Text] [Related]
13. Molecular properties of central and peripheral histamine H1 and H2 receptors.
Carman-Krzan M; Lipnik-Stangelj M
Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
[TBL] [Abstract][Full Text] [Related]
14. Roles of Lys191 and Lys179 in regulating thermodynamic binding forces of ligands to determine their binding affinity for human histamine H
Kobayashi C; Tanaka A; Yasuda T; Hishinuma S
Biochem Pharmacol; 2020 Oct; 180():114185. PubMed ID: 32738199
[TBL] [Abstract][Full Text] [Related]
15. Characterization of interactions between local anesthetics and histamine H
Cao J; Yang L; Wang Y; Liu R; Zhang T; He L
J Pharm Biomed Anal; 2021 Mar; 196():113911. PubMed ID: 33497977
[TBL] [Abstract][Full Text] [Related]
16. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio.
Kubo N; Senda M; Ohsumi Y; Sakamoto S; Matsumoto K; Tashiro M; Okamura N; Yanai K
Hum Psychopharmacol; 2011 Mar; 26(2):133-9. PubMed ID: 21433074
[TBL] [Abstract][Full Text] [Related]
17. Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes.
Ghoneim OM; Legere JA; Golbraikh A; Tropsha A; Booth RG
Bioorg Med Chem; 2006 Oct; 14(19):6640-58. PubMed ID: 16782354
[TBL] [Abstract][Full Text] [Related]
18. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
[TBL] [Abstract][Full Text] [Related]
19. Characterization of histamine H1 binding sites on human T lymphocytes by means of 125I-iodobolpyramine. Preferential expression of H1 receptors on CD8 T lymphocytes.
Villemain FM; Bach JF; Chatenoud LM
J Immunol; 1990 Feb; 144(4):1449-54. PubMed ID: 1968079
[TBL] [Abstract][Full Text] [Related]
20. Changes in pH differently affect the binding properties of histamine H1 receptor antagonists.
Gillard M; Chatelain P
Eur J Pharmacol; 2006 Jan; 530(3):205-14. PubMed ID: 16388798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
